NASDAQ · Biotechnology

XNCR (XNCR) Stock

$20.21 -5.96% NASDAQ: XNCR Healthcare

Valuation

MetricValue
Price$20.21
Market Cap$1.50B
P/E Ratio-10.37
P/B Ratio1.50
P/S Ratio8.42
EPS (TTM)$-1.24
52-Week High$20.45
52-Week Low$6.92
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-14.47%
ROA-10.51%
ROCE-28.03%
Gross Margin-140.48%
Operating Margin-141.27%
Net Margin-1.77%
Debt/Equity0.34
Current Ratio6.25

Annual Financials (USD)

Metric20212022202320242025
Revenue$275.0M$165.0M$175.0M$110.0M$126.0M
Operating Profit$44.0M$-82.0M$-132.0M$-178.0M$-178.0M
Net Profit$83.0M$-55.0M$-133.0M$-233.0M$-92.0M
EPS$1.37$-0.93$-2.08$-3.58$-1.24
Op Margin15.9%-50.1%-75.8%-161.5%-141.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$838.0M$846.0M$953.0M$952.0M$875.0M
Total Liabilities$105.0M$119.0M$284.0M$278.0M$240.0M
Cash$143.0M$54.0M$54.0M$41.0M$54.0M
Borrowings$34.0M$60.0M$83.0M$232.0M$188.0M

Latest News

VERAXA Biotech Stock in Focus as Lead Cancer Program Reaches Development Milestone Exec Edge · Jul 2, 2026 Xencor (XNCR) Stock Draws Fresh Price Target Split As Pipeline Progress Meets Caution Simply Wall St. · Jun 14, 2026 Bi/Multispecific Drugs in Oncology Analytical Tool Featuring Top Developers - Amgen, Hoffmann-La Roche, J&J, Xencor, Biocytogen - Unlocking New Precision, Immune Activation, and Therapeutic Potential GlobeNewswire · May 12, 2026 These Analysts Think Xencor, Inc.'s (NASDAQ:XNCR) Sales Are Under Threat Simply Wall St. · May 8, 2026 Xencor (XNCR) Reports Q1 Loss, Lags Revenue Estimates Zacks · May 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-17.0M$24.0M$-78.0M$-202.0M$-135.0M
Investing Cash Flow$-62.0M$-163.0M$-129.0M$-14.0M$137.0M
Financing Cash Flow$14.0M$6.0M$183.0M$-4.0M$-2.0M
Net Cash Flow$-20.0M$-90.0M$0$-13.0M$13.0M
Free Cash Flow$-33.0M$-19.0M$-96.0M$-208.0M$-138.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-23.03%
Quick Ratio6.57
Interest Coverage-5.56
Return 1Y104.08%
Return 3Y-19.36%
Return 5Y-54.18%

Ownership

Insiders Held1.22%
Institutions Held115.39%
Institutions Float Held116.82%
Institutional HolderSharesReport Date
Blackrock Inc.13,035,9182026-03-31
Primecap Management Company10,338,0222026-03-31
BVF Inc.7,133,7202026-03-31
RTW Investments LP6,777,4612026-03-31
RA Capital Management, L.P.4,897,2372026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About XNCR

XNCR is led by CEO Bassil I. Dahiyat, employs 250 people, headquartered in US, publicly traded since 2013.

XNCR stock trades at $20.21 with a market capitalization of $1.50B. The stock is valued at a price-to-earnings (P/E) ratio of -10.37, price-to-book of 1.50, price-to-sales of 8.42. Over the past 52 weeks the stock has ranged between $6.92 and $20.45, and currently trades 1.2% below its 52-week high.

On profitability, XNCR generates a return on equity (ROE) of -14.47%, return on capital employed of -28.03%, an operating margin of -141.27%, a net profit margin of -1.77%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides